Nonanemic patients do not benefit from autologous blood donation before total hip replacement

HSS Journal

Volumn 6, Issue 1, 2010, Pages 66-70

  Boettner, Friedrich ^a   Altneu, Eric I ^a   Williams, Brendan A ^b   Hepinstall, Matthew ^a   Sculco, Thomas P ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Allogeneic; Autologous; Blood management; Total hip arthroplasty; Total hip replacement; Transfusion

Indexed keywords

EID: 76649138281     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-009-9145-4     Document Type: Article

References (18)

1. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J. Bone Jt. Surg. Am. 81(1): 2-10.
2. Biesma DH, Marx JJ, van de Wiel A (1994) Collection of autologous blood before elective hip replacement. A comparison of the results with the collection of two and four units. J. Bone Jt. Surg. Am. 76(10): 1471-1475.
3. Billote DB, Glisson SN, Green D, Wixson RL (2002) A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J. Bone Jt. Surg. Am. 84-A(8): 1299-1304.
4. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE (2004) Risks associated with blood transfusion after total knee arthroplasty. J. Arthroplast. 19(3): 281-287.
5. Couvret C, Laffon M, Baud A, Payen V, Burdin P, Fusciardi J (2004) A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty. Anesth. Analg. 99(1): 262-271.
6. Cushner FD, Hawes T, Kessler D, Hill K, Scuderi GR. Orthopaedic-induced anemia: the fallacy of autologous donation programs. Clin Orthop Relat Res. 2005(431): 145-149.
7. Cushner FD, Lee GC, Scuderi GR, Arsht SJ, Scott WN (2006) Blood loss management in high-risk patients undergoing total knee arthroplasty: a comparison of two techniques. J. Knee Surg. 19(4): 249-253.
8. Deutsch A, Spaulding J, Marcus RE (2006) Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty. J. Arthroplast. 21(5): 628-635.
9. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, Fink A, Brook R (1995) The cost effectiveness of preoperative autologous blood donations. N. Engl. J. Med. 332(11): 719-724.
10. Faris PM, Ritter MA, Abels RI (1996) The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J. Bone Jt. Surg. Am. 78(1): 62-72.
11. Forgie MA, Wells PS, Laupacis A, Fergusson D (1998) Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch. Intern. Med. 158(6): 610-616.
12. Green WS, Toy P, Bozic KJ, Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. J Arthroplast. 2009 (in press).
13. Hardwick ME, Morris BM, Colwell CW, Jr., Two-dose epoetin alfa reduces blood transfusions compared with autologous donation. Clin. Orthop. Relat. Res. 2004(423): 240-244.
14. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL (2000) Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J. Bone Jt. Surg. Am. 82(1): 89-100.
15. Lee GC, Cushner FD (2007) The effects of preoperative autologous donations on perioperative blood levels. J. Knee Surg. 20(3): 205-209.
16. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D (2007) Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br. J. Anaesth. 99(6): 794-800.
17. Slappendel R, Dirksen R, Weber EW, van der Schaaf DB (2003) An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop. Scand. 74(5): 569-575.
18. Walsh M, Preston C, Bong M, Patel V, Di Cesare PE (2007) Relative risk factors for requirement of blood transfusion after total hip arthroplasty. J. Arthroplast. 22(8): 1162-1167.